Informações:
Falhas:
ID
28243
Descrição
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00873275
Link
https://clinicaltrials.gov/show/NCT00873275
Palavras-chave
Versões (1)
- 29/12/2017 29/12/2017 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
29 de dezembro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Colorectal Cancer NCT00873275
Eligibility Colorectal Cancer NCT00873275
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT00873275
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Colorectal cancer metastatic Advanced
Item
patients with advanced, biopsy proven metastatic colorectal cancer
boolean
C0948380 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,2])
Karnofsky Performance Status
Item
karnofsky performance status >= 80
boolean
C0206065 (UMLS CUI [1])
Prior Therapy Completed | Side effects Patient recovered
Item
prior therapy completed at least 3 weeks before protocol treatment initiation with recovery from any side-effects
boolean
C1514463 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0879626 (UMLS CUI [2,1])
C1115804 (UMLS CUI [2,2])
C0205197 (UMLS CUI [1,2])
C0879626 (UMLS CUI [2,1])
C1115804 (UMLS CUI [2,2])
Serum albumin normal | Serum prealbumin Normal
Item
serum albumin and prealbumin within normal limits
boolean
C0580492 (UMLS CUI [1])
C0518013 (UMLS CUI [2,1])
C0205307 (UMLS CUI [2,2])
C0518013 (UMLS CUI [2,1])
C0205307 (UMLS CUI [2,2])
Alanine aminotransferase measurement
Item
alanine aminotransferase (alt) within 3 x upper limit of normal
boolean
C0201836 (UMLS CUI [1])
Alkaline phosphatase measurement
Item
alkaline phosphatase within 3 x upper limit of normal
boolean
C0201850 (UMLS CUI [1])
Serum bilirubin normal
Item
serum bilirubin within normal limits
boolean
C0428443 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count >= 1500/ul
boolean
C0948762 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine within 1.5 x upper limit of normal
boolean
C0201976 (UMLS CUI [1])
Informed Consent
Item
ability to understand and sign an institutional review board (irb) approved informed consent
boolean
C0021430 (UMLS CUI [1])
Contraceptive methods | Childbearing Potential Pregnancy Absent
Item
ability to use appropriate contraception and no evidence of pregnancy in female patients of reproductive potential
boolean
C0700589 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C3831118 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Medical condition Therapeutic procedure At risk | Mental disorders Therapeutic procedure At risk
Item
significant medical or psychiatric condition that would make treatment unsafe
boolean
C3843040 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C0004936 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])
C0087111 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C0004936 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])
Systemic steroids
Item
use of systemic steroids use within 7 days from start of trial
boolean
C2825233 (UMLS CUI [1])
Breast Feeding
Item
nursing women
boolean
C0006147 (UMLS CUI [1])
Protocol Compliance Unable
Item
patients unable to comply with protocol related studies and follow up
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])
Weight decreased Percentage
Item
weight loss of greater than 10% in the last 6 months
boolean
C1262477 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,2])